Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer confirmed by a pathology report.
- People whose physical functioning is rated at 0 or 1 on a standard scale used to measure how well a person can carry out daily activities (confirm with trial site).
- People between the ages of 18 and 75 years old.
- People who are receiving a chemotherapy treatment plan that includes taxane-based drugs, either on their own or combined with other medicines.
- People who have previously received taxane-based chemotherapy for more than 6 months.
- People who have been experiencing nerve-related symptoms (such as numbness, tingling, or pain) rated at grade 1 or higher for more than 2 weeks, as defined by standard cancer side effect guidelines.
- People who are willing to participate in the trial and have signed a consent form agreeing to take part.
- People who are able to attend regular follow-up appointments.
- People who have complete medical records relating to their pathology available.
Who may not be able to join:
- People who do not have a breast cancer diagnosis.
- People who have received electroacupuncture treatment in the 6 months before the trial begins.
- People who had to stop their standard chemotherapy early due to side effects that were too severe to tolerate.
- People who had nerve damage or peripheral neuropathy before enrolling in the trial.
- People who have unstable heart disease or who had a heart attack in the 6 months before the trial starts.
- People who have active skin conditions, open skin wounds, or skin infections in areas where electroacupuncture would be applied.
- People with epilepsy whose seizures are not currently under control.
- People who have been diagnosed with another type of cancer in addition to breast cancer.
- People who are pregnant or breastfeeding.
- People who have declined to participate in the clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-18729989935
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity Index （FACT/GOG-NTX）
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.